Submit Deal

EISAI

HQ - Tokyo

Summary

Eisai is a pharmaceutical company that focuses on discovering, developing, and commercializing innovative products for the treatment of various diseases, including neurology and oncology.

Deals Overview

Total Deals3

Valued Deals2

Total Value£ 84 M

Avg. Deal Size£ 42 M

Market Context

Senior Management

Haruo Naito
CEO
Keisuke Naito
Senior Vice President

Sort

04 May 2021|Finland|Medical Equipment

Target: OURA HEALTH LTD

Bidder: NEXT VENTURES

4 Service Providers

3 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 72 M

Value

07 Nov 2022|Myanmar|Pharmaceuticals

Target: MYONAL

Bidder: DKSH HOLDING AG

4 Service Providers

2 Bidder | 2 Vendor

9 Dealmakers

8 Bidder | 1 Vendor

n/a

Value

06 Mar 2024|United States|Biotechnology

Target: C2N DIAGNOSTICS

Bidder: EISAI

3 Service Providers

2 Target | 1 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 11 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy